# Olema Pharmaceuticals, Inc.: Form SC 13D/A, filed Dec 4, 2024

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: SC 13D/A
- Filed: 2024-12-04
- Accepted by EDGAR: Dec 5, 2024, 00:49 ET
- Period: not reported
- Accession: 0000921895-24-002885
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000092189524002885/sc13da307422olma_12042024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000092189524002885/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000092189524002885/sc13da307422olma_12042024.htm

Filed Dec 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000921895-24-002885. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.